COVID-19 and persons with substance use disorders: Inequities and mitigation strategies

References

• Tanne JH, Hayasaki E, Zastrow M, Pulla P, Smith P, Rada AG. Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide. BMJ. 2020;368:m1090.
   PubMed Web of Science ®Google Scholar
• Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020. [epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Brown EE, Kumar S, Rajji TK, Pollock BG, Mulsant BH. Anticipating and mitigating the impact of COVID-19 pandemic on Alzheimer’s disease and related dementias. Am J Geriatr Psychiatry. 2020. [epub ahead of print].
   Web of Science ®Google Scholar
• Kozloff N, Mulsant B, Stergiopoulos V, Voineskos A. The COVID-19 global pandemic: implications for people with schizophrenia and related disorders. Schizophr Bull. 2020. [epub ahead of print].
   PubMedGoogle Scholar
• Yao H, Chen JH, Xu YF. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21.
   PubMed Web of Science ®Google Scholar
• American Society of Addiction Medicine. Definition of addiction. https://www.asam.org/Quality-Science/definition-of-addiction. Accessed May 20, 2020.
   Google Scholar
• Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(1):S135–S145.
   PubMedGoogle Scholar
• Guydish J, Passalacqua E, Pagano A, et al. An international systematic review of smoking prevalence in addiction treatment. Addiction. 2016;111(2):220–230.
   PubMed Web of Science ®Google Scholar
• Palmer F, Jaffray M, Moffat MA, et al. Prevalence of common chronic respiratory diseases in drug misusers: a cohort study. Prim Care Respir J. 2012;21(4):377–383.
   PubMedGoogle Scholar
• Clement S, Schauman O, Graham T, et al. What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychol Med. 2015;45(1):11–27.
   PubMed Web of Science ®Google Scholar
• van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Comparing stigmatising attitudes towards people with substance use disorders between the general public, GPs, mental health and addiction specialists and clients. Int J Soc Psychiatry. 2015;61(6):539–549.
   PubMed Web of Science ®Google Scholar
• Tsai J, Wilson M. COVID-19: a potential public health problem for homeless populations. Lancet Public Health. 2020;5(4):e186–e187.
   PubMed Web of Science ®Google Scholar
• Bauer CMT, Morissette MC, Stampfli MR. The influence of cigarette smoking on viral infections: translating bench science to impact COPD pathogenesis and acute exacerbations of COPD clinically. Chest. 2013;143(1):196–206.
   PubMed Web of Science ®Google Scholar
• Gates P, Jaffe A, Copeland J. Cannabis smoking and respiratory health: consideration of the literature. Respirology. 2014;19(5):655–662.
   PubMed Web of Science ®Google Scholar
• Walker PP, Thwaite E, Amin S, Curtis JM, Calverley P. The association between heroin inhalation and early onset emphysema. Chest. 2015;148(5):1156–1163.
   PubMed Web of Science ®Google Scholar
• Loftis JM, Huckans M. Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy. Pharmacol Ther. 2013;139(2):289–300.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Ohlsson H, Sundquist K, Sundquist J. Drug abuse-associated mortality across the lifespan: a population-based longitudinal cohort and co-relative analysis. Soc Psychiatry Psychiatr Epidemiol. 2017;52(7):877–886.
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239.
   PubMed Web of Science ®Google Scholar
• Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020;18:20.
   PubMed Web of Science ®Google Scholar
• Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med. 2020;75:107–108.
   PubMed Web of Science ®Google Scholar
• Druss BG, von Esenwein SA. Improving general medical care for persons with mental and addictive disorders: systematic review. Gen Hosp Psychiatry. 2006;28(2):145–153.
   PubMed Web of Science ®Google Scholar
• Kim TW, Samet JH, Cheng DM, et al. The spectrum of unhealthy drug use and quality of care for hypertension and diabetes: a longitudinal cohort study. BMJ Open. 2015;5(12):e008508.
   PubMed Web of Science ®Google Scholar
• Emanuel EJ, Persad G, Upshur R, et al. Fair allocation of scarce medical resources in the time of COVID-19. N Engl J Med. 2020;382(21):2049–2055.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363–371.
   PubMed Web of Science ®Google Scholar
• al’Absi M, Carr SB, Bongard S. Anger and psychobiological changes during smoking abstinence and in response to acute stress: prediction of smoking relapse. Int J Psychophysiol. 2007;66(2):109–115.
   PubMed Web of Science ®Google Scholar
• Blaine SK, Sinha R. Alcohol, stress, and glucocorticoids: from risk to dependence and relapse in alcohol use disorders. Neuropharmacology. 2017;122:136–147.
   PubMed Web of Science ®Google Scholar
• Chao T, Radoncic V, Hien D, Bedi G, Haney M. Stress responding in cannabis smokers as a function of trauma exposure, sex, and relapse in the human laboratory. Drug Alcohol Depend. 2018;185:23–32.
   PubMed Web of Science ®Google Scholar
• Preston KL, Epstein DH. Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl). 2011;218(1):29–37.
   PubMed Web of Science ®Google Scholar
• Bonnet U, Preuss UW. The cannabis withdrawal syndrome: current insights. Subst Abuse Rehabil. 2017;8:9–37.
   PubMed Web of Science ®Google Scholar
• Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment. Subst Abus. 2020;41(2):147–149.
   PubMed Web of Science ®Google Scholar
• Becker WC, Fiellin DA. When epidemics collide: Coronavirus Disease 2019 (COVID-19) and the opioid crisis. Ann Intern Med. 2020. [epub ahead of print].
   Web of Science ®Google Scholar
• Akiyama MJ, Spaulding AC, Rich JD. Flattening the curve for incarcerated populations - Covid-19 in jails and prisons. N Engl J Med. 2020;382(22):2075–2077.
   PubMed Web of Science ®Google Scholar
• Joudrey PJ, Khan MR, Wang EA, et al. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019;14(1):17.
   PubMedGoogle Scholar
• Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. 2020;33(2):e100213.
   PubMed Web of Science ®Google Scholar
• Cava MA, Fay KE, Beanlands HJ, McCay EA, Wignall R. The experience of quarantine for individuals affected by SARS in Toronto. Public Health Nurs. 2005;22(5):398–406.
   PubMed Web of Science ®Google Scholar
• Lee AM, Wong JG, McAlonan GM, et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry. 2007;52(4):233–240.
   PubMed Web of Science ®Google Scholar
• Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566–576.
   PubMed Web of Science ®Google Scholar
• Goeders NE. Stress, motivation, and drug addiction. Curr Dir Psychol Sci. 2004;13(1):33–35.
   Web of Science ®Google Scholar
• Substance abuse and mental health services administration (SAMHSA) Virtual Recovery Sources. https://www.samhsa.gov/sites/default/files/virtual-recovery-resources.pdf. Accessed May 20, 2020.
   Google Scholar
• Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179–187.
   PubMed Web of Science ®Google Scholar
• Matkin W, Ordonez-Mena JM, Hartmann-Boyce J. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2019;5:CD002850.
   PubMedGoogle Scholar
• Taylor GMJ, Dalili MN, Semwal M, Civljak M, Sheikh A, Car J. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2017;9:CD007078.
   PubMedGoogle Scholar
• Zaheer S, Garofalo V, Rodie D, et al. Computer-aided telephone support for primary care patients with common mental health conditions: randomized controlled trial. JMIR Ment Health. 2018;5(4):e10224.
   PubMed Web of Science ®Google Scholar
• Quanbeck A, Chih MY, Isham A, Gustafson D. Mobile delivery of treatment for alcohol use disorders: a review of the literature. Alcohol Res Curr Rev. 2014;36(1):111–122.
   Web of Science ®Google Scholar
• Legha RK, Moore L, Ling R, Novins D, Shore J. Telepsychiatry in an Alaska native residential substance abuse treatment program. Telemed J e-Health. 2019. [epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Varker T, Brand RM, Ward J, Terhaag S, Phelps A. Efficacy of synchronous telepsychology interventions for people with anxiety, depression, posttraumatic stress disorder, and adjustment disorder: a rapid evidence assessment. Psychol Serv. 2019;16(4):621–635.
   PubMed Web of Science ®Google Scholar
• Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382(18):1679–1681.
   PubMed Web of Science ®Google Scholar
• Marsch LA, Dallery J. Advances in the psychosocial treatment of addiction: the role of technology in the delivery of evidence-based psychosocial treatment. Psychiatr Clin North Am. 2012;35(2):481–493.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. 2014. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-48, HHS Publication No.(SMA) 14-4863, 1–143.
   Google Scholar
• American Society of Addiction Medicine; Placement Criteria. https://www.asam.org/asam-criteria/about. Accessed on May 20, 2020.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA) Opioid treatment program (OTP) guidance. www.samhsa.gov/sites/default/files/otp-guidance-20200316.pdf. Accessed on May 20, 2020.
   Google Scholar
• McDermott MM, Newman AB. Preserving clinical trial integrity during the coronavirus pandemic. JAMA. 2020;323(21):2135.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. FDA guidance on conduct of clinical trials of medical products during COVID-19 pandemic: guidance for industry, investigators, and institutional review boards. 2020. [epub ahead of print].
   Google Scholar
• National Institutes of Health. Guidance for NIH-funded clinical trials and human subjects studies affected by COVID-19. 2020. [epub ahead of print].
   Google Scholar